Perceptive Advisors
Biotech-focused crossover fund investing across public and private life sciences.
VC
Bio/Healthcare
📍 New York, NY
Founded 1999
AUM
$8.0B
as of 2026-Q1
MID
Perceptive Advisors is a New York biotechnology-focused investment firm founded in 1999 by Joseph Edelman, investing across the capital structure in public and private life-sciences companies. It manages about $8 billion, and its investments include Nuvation Bio, Absci, Scribe Therapeutics and Marea Therapeutics.
Notable Partners
Joseph Edelman
Investment Focus
Stages
Series A · Series B · Crossover · Late-stage
BioCrossover
Investor data reflects publicly disclosed AUM, fund sizes, and portfolio holdings as of 2026-Q1. Refreshed periodically.